Literature DB >> 18635577

The identification and characterization of a FOXL2 response element provides insights into the pathogenesis of mutant alleles.

Bérénice A Benayoun1, Sandrine Caburet, Aurélie Dipietromaria, Marc Bailly-Bechet, Frank Batista, Marc Fellous, Daniel Vaiman, Reiner A Veitia.   

Abstract

The Forkhead transcription factor FOXL2 plays a crucial role in ovarian development and maintenance. In humans, its mutations lead to craniofacial abnormalities, isolated or associated with ovarian dysfunction. Using a combinatorial approach, we identified and characterized a FoxL2 response element (FLRE) and showed that it is highly specific and that it diverges from that of other Forkhead transcription factors. This specificity should prevent aberrant regulation of FOXL2 targets by other members of the family and should prevent ectopic activation of the ovarian differentiation program in testes. We provide evidence that the FLRE is used in naturally occurring promoters. We show that polyAlanine expansions of FOXL2, which are the most frequent pathogenic mutations, induce a length-dependent loss of response on different artificial promoter reporters depending on the number and sequence of the FLREs that they contain. Thus, we provide clear mechanistic evidence explaining how the architecture of promoters influences their sensitivity to decreased transcription factor availability. Furthermore, we speculate that the generally absent ovarian phenotype of patients carrying the most frequent polyAlanine expansion should come from its ability to properly regulate high-affinity ovarian targets. The existence of critical high-affinity ovarian targets would be compatible with the role of FOXL2 in reproduction and ensure developmental and functional robustness. Taken together, our results give mechanistic insights on the molecular pathogenesis of FOXL2 polyAlanine expansions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635577     DOI: 10.1093/hmg/ddn209

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  20 in total

1.  Clinical Characteristics and Mutation Analyses of Ovarian Sertoli-Leydig Cell Tumors.

Authors:  Zhen Yuan; Xiao Huo; Dezhi Jiang; Mei Yu; Dongyan Cao; Huanwen Wu; Keng Shen; Jiaxin Yang; Ying Zhang; Huimei Zhou; Yao Wang
Journal:  Oncologist       Date:  2020-08-11

2.  Program specificity for Ptf1a in pancreas versus neural tube development correlates with distinct collaborating cofactors and chromatin accessibility.

Authors:  David M Meredith; Mark D Borromeo; Tye G Deering; Bradford H Casey; Trisha K Savage; Paul R Mayer; Chinh Hoang; Kuang-Chi Tung; Manonmani Kumar; Chengcheng Shen; Galvin H Swift; Raymond J Macdonald; Jane E Johnson
Journal:  Mol Cell Biol       Date:  2013-06-10       Impact factor: 4.272

3.  FOXL2 transcriptionally represses Sf1 expression by antagonizing WT1 during ovarian development in mice.

Authors:  Kei Takasawa; Kenichi Kashimada; Emanuele Pelosi; Masatoshi Takagi; Tomohiro Morio; Hiroshi Asahara; David Schlessinger; Shuki Mizutani; Peter Koopman
Journal:  FASEB J       Date:  2014-01-22       Impact factor: 5.191

Review 4.  A FoxL in the Smad house: activin regulation of FSH.

Authors:  Djurdjica Coss; Pamela L Mellon; Varykina G Thackray
Journal:  Trends Endocrinol Metab       Date:  2010-07-02       Impact factor: 12.015

5.  Mutant Forkhead L2 (FOXL2) proteins associated with premature ovarian failure (POF) dimerize with wild-type FOXL2, leading to altered regulation of genes associated with granulosa cell differentiation.

Authors:  Fang-Ting Kuo; Ikuko K Bentsi-Barnes; Gillian M Barlow; Margareta D Pisarska
Journal:  Endocrinology       Date:  2011-08-23       Impact factor: 4.736

Review 6.  Minireview: Activin Signaling in Gonadotropes: What Does the FOX say… to the SMAD?

Authors:  Jérôme Fortin; Luisina Ongaro; Yining Li; Stella Tran; Pankaj Lamba; Ying Wang; Xiang Zhou; Daniel J Bernard
Journal:  Mol Endocrinol       Date:  2015-05-05

Review 7.  Fox tales: regulation of gonadotropin gene expression by forkhead transcription factors.

Authors:  Varykina G Thackray
Journal:  Mol Cell Endocrinol       Date:  2013-10-04       Impact factor: 4.102

8.  A novel role for the forkhead transcription factor FOXL2 in activin A-regulated follicle-stimulating hormone beta subunit transcription.

Authors:  Pankaj Lamba; Jérôme Fortin; Stella Tran; Ying Wang; Daniel J Bernard
Journal:  Mol Endocrinol       Date:  2009-03-26

9.  Human forkhead L2 represses key genes in granulosa cell differentiation including aromatase, P450scc, and cyclin D2.

Authors:  Ikuko K Bentsi-Barnes; Fang-Ting Kuo; Gillian M Barlow; Margareta D Pisarska
Journal:  Fertil Steril       Date:  2009-11-14       Impact factor: 7.329

10.  Functional exploration of the adult ovarian granulosa cell tumor-associated somatic FOXL2 mutation p.Cys134Trp (c.402C>G).

Authors:  Bérénice A Benayoun; Sandrine Caburet; Aurélie Dipietromaria; Adrien Georges; Barbara D'Haene; P J Eswari Pandaranayaka; David L'Hôte; Anne-Laure Todeschini; Sankaran Krishnaswamy; Marc Fellous; Elfride De Baere; Reiner A Veitia
Journal:  PLoS One       Date:  2010-01-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.